FibroGen (FGEN)
(Delayed Data from NSDQ)
$0.39 USD
0.00 (1.23%)
Updated Sep 9, 2024 04:00 PM ET
After-Market: $0.39 0.00 (-1.22%) 7:58 PM ET
3-Hold of 5 3
D Value D Growth F Momentum F VGM
Cash flow Statements
Fiscal Year End for FibroGen, Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -284.23 | -293.65 | -290.02 | -189.29 | -76.97 |
Depreciation/Amortization & Depletion | 4.87 | 12.22 | 17.29 | 22.15 | 17.79 |
Net Change from Assets/Liabilities | -119.69 | 70.43 | 60.08 | 174.63 | -85.66 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | 84.03 | 65.07 | 130.42 | 74.11 | 66.14 |
Net Cash From Operating Activities | -315.02 | -145.93 | -82.23 | 81.60 | -78.71 |
Property & Equipment | -2.52 | -3.74 | -5.19 | -3.99 | -5.76 |
Acquisition/ Disposition of Subsidiaries | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | 155.52 | 127.85 | -396.79 | 456.48 | 125.77 |
Other Investing Activities | 0.66 | -35.00 | -25.00 | 0.00 | 0.00 |
Net Cash from Investing Activities | 153.66 | 89.12 | -426.97 | 452.49 | 120.02 |
Uses of Funds
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 52.14 | 4.18 | 12.70 | 37.83 | 20.78 |
Issuance (Repayment) of Debt | 73.59 | -0.54 | -5.89 | -13.02 | -12.33 |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | -2.98 | 43.13 | -7.37 | -11.46 | -12.75 |
Net Cash from Financing Activities | 122.75 | 46.78 | -0.56 | 13.34 | -4.30 |
Effect of Exchange Rate Changes | -3.40 | -5.48 | 2.60 | 4.70 | -0.01 |
Net Change In Cash & Equivalents | -42.01 | -15.52 | -507.17 | 552.13 | 37.01 |
Cash at Beginning of Period | 155.70 | 171.22 | 678.39 | 126.27 | 89.26 |
Cash at End of Period | 113.69 | 155.70 | 171.22 | 678.39 | 126.27 |
Diluted Net EPS | -2.92 | -3.14 | -3.14 | -2.11 | -0.89 |
Fiscal Year End for FibroGen, Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -48.48 | -32.93 | -284.23 | -228.00 | -164.39 |
Depreciation/Amortization & Depletion | -0.08 | -0.47 | 4.87 | 4.40 | 3.86 |
Net Change from Assets/Liabilities | -66.49 | -34.05 | -119.69 | -146.35 | -111.77 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | 15.89 | 8.17 | 84.03 | 73.25 | 60.13 |
Net Cash From Operating Activities | -99.16 | -59.29 | -315.02 | -296.70 | -212.16 |
Property & Equipment | -0.04 | 0.00 | -2.52 | -2.27 | -1.58 |
Acquisition/ Disposition of Subsidiaries | 0.00 | -0.03 | 0.00 | 0.66 | 0.66 |
Investments | 123.56 | 51.31 | 155.52 | 145.03 | 90.13 |
Other Investing Activities | 0.00 | 0.00 | 0.66 | 0.00 | 0.00 |
Net Cash from Investing Activities | 123.52 | 51.28 | 153.66 | 143.42 | 89.20 |
Uses of Funds
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 0.12 | 0.00 | 52.14 | 52.09 | 52.09 |
Issuance (Repayment) of Debt | -0.02 | -0.01 | 73.59 | 73.65 | 73.67 |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | -0.23 | -0.15 | -2.98 | -2.75 | -2.75 |
Net Cash from Financing Activities | -0.13 | -0.17 | 122.75 | 123.00 | 123.02 |
Effect of Exchange Rate Changes | 2.80 | 0.22 | -3.40 | -4.50 | -3.17 |
Net Change In Cash & Equivalents | 27.03 | -7.95 | -42.01 | -34.79 | -3.12 |
Cash at Beginning of Period | 113.69 | 113.69 | 155.70 | 155.70 | 155.70 |
Cash at End of Period | 140.71 | 105.73 | 113.69 | 120.91 | 152.59 |
Diluted Net EPS | -0.16 | -0.33 | -0.56 | -0.65 | -0.90 |